Rosty Raykov - 03 Nov 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Rostislav Roykov
Issuer symbol: FENC
Transactions as of: 03 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Nov 2023, 17:19:04 UTC
Previous filing: 03 Apr 2023
Next filing: 09 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FENC	Common shares	Options Exercise	$118,921	+74,793	+32%	$1.59^*	307,631	03 Nov 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Option Contract	Options Exercise	$118,921	-74,793	-4.5%	$1.59^*	1,596,040	03 Nov 2023	Options	74,793	$1.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired through the exercise of an option contract with a strike price of $1.59 and an expiration date of January 24, 2024.
F2	Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024.